陕西奥星制药有限公司 BIOSTAR PHARMACEUTICALS INC
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Biostar Pharmaceuticals Inc. Postpones its 2015 Annual Meeting of Shareholders 2015-12-05 05:00
BiostarPharmaceuticals,Inc. Announces Its Quarterly Results for Three Months Ended September 30, 2015 2015-11-24 05:00
Biostar Pharmaceuticals,Inc. Announces Its Quarterly and Half Year Results for 2015 2015-08-20 04:30
Biostar Pharmaceuticals, Inc. Announces Its Full Year and Fourth Quarter 2014 Financial Results 2015-04-16 04:30
Biostar Pharmaceuticals, Inc. Announces Signing of Joint Research and Development Agreement with Northwest University for Further Development of Danshensu Yibingzhi (IDHP), a Class One Drug for Treatment of Cardiovascular Diseases 2015-01-08 21:00
Biostar Pharmaceuticals, Inc. Announces Third Quarter 2014 Financial Results 2014-11-14 22:00
Biostar Pharmaceuticals, Inc. Files a PRC Patent Application for Oleanolic Acid Injection, its New Drug Product for Hepatitis B and Liver Cancer 2014-09-18 20:00
Biostar Pharmaceuticals Inc. Engaged Chief Scientist Professor Xiaohui Zheng To Preside Over The Company's Product Development Projects 2014-08-27 20:00
Biostar Pharmaceuticals, Inc. Announces Second Quarter 2014 Financial Results 2014-08-14 20:00
Biostar Pharmaceuticals Inc. Established a Sales and Marketing Task Team to Promote Sales to Hospital Facilities in Ten PRC Provinces 2014-08-04 20:00
Biostar Pharmaceuticals, Inc. Announces First Quarter 2014 Financial Results 2014-05-16 04:01
Biostar Pharmaceuticals, Inc. Announces Full Year 2013 Financial Results 2014-04-01 04:30
Biostar Announces Execution of Agreement for $4.1 Million Registered Direct Offering of Shares of Common Stock and Warrants 2014-03-10 20:00
Biostar Pharmaceuticals, Inc. Partners with Shaanxi University of Chinese Medicine to Co-develop Liver Cancer Drug 2014-03-06 21:00
Biostar Pharmaceuticals, Inc. Expects 2013 Yearly Revenue Growth above 20% with Break Even Operating Results as Compared With Last Year's USD$21.8 Million Loss from Operations 2014-02-20 21:00
Biostar Held Its Strategic Development Seminar; Identified Development Planning for 2014 - 2016 2014-02-14 21:00
Biostar Pharmaceuticals, Inc. Announces the Designation of its PRC Operating Subsidiary as the Shaanxi Province Liver Disease Health Education Base 2014-01-15 21:00
Biostar Pharmaceuticals, Inc. Announces Opening of a Sales Office in Gansu Province, PRC 2014-01-10 21:00
Biostar Pharmaceuticals, Inc. Announces Third Quarter 2013 Financial Results 2013-11-15 05:00
Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2013 Third Quarter Earnings Conference Call on Friday, November 15, 2013 at 9:30 a.m. ET 2013-11-14 21:00
1 2 3 4 5 7